The Effect of MK 0633 in Patients With Atherosclerosis (0633-008)(COMPLETED)

A Clinical Study to Evaluate the Efficacy and Safety of MK0633 in Patients With Atherosclerosis

A study to test the effects of study drug (MK 0633) on patients with Atherosclerotic disease

Inclusion Criteria:

• Patients with plaque in coronary or leg arteries, known as atherosclerosis or peripheral vascular disease
• Inflammatory marker found in your blood, known as hsCRP > 0.5 mg/L

Exclusion Criteria:

• Age < 40 or > 85
• Female
• Heart attack, coronary artery bypass, stroke or unstable angina in last 3 months
• Liver diseased or abnormalities
• HIV infection
• Lupus, rheumatoid arthritis, cancer <5 years